IPOGrid
0001922335
IPO filing research

Syra Health Corp

Services-Employment Agencies · SYRA

follow-on trading filed OTC S-1

Syra Health Corp IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: S-1 on 2026-09-14. Current deal snapshot: exchange OTC.

Filing Timeline

SEC EDGAR
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows EFFECT in the pre-IPO sequence.
Price $0.64 · 3,203,125 shares · Gross proceeds $2,050,000
Class A · Ticker SYRA · Series B Warrants exercisable at $0.64 per share until 2029 · Selling stockholders only · Use of proceeds Selling stockholders may use proceeds for general corporate purposes · Flags warrants
2026-09-14 · 0001493152-26-042591
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B4 and marks the registration effective.
2025-02-07 · 9999999995-25-000359
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $0.64 · 3,203,125 shares · Gross proceeds $2,050,000
A · Exchange Nasdaq Capital Market · Ticker SYRA · Class A Common Stock with Series A and B Warrants · Series A Warrants (exercise $0.64, 18-month expiry), Series B Warrants (exercise $0.64, 5-year expiry), Placement Agent Warrants (5% of shares sold at $0.80) · Use of proceeds For marketing, sales, application development, research and development, and general corporate purposes · Flags warrants · Underwriters Rodman & Renshaw LLC
2024-09-12 · 0001493152-24-036069
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2024-09-11 · 9999999995-24-002795
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
Price $1.32 · 3,787,878 shares
Class A · Exchange Nasdaq Capital Market · Ticker SYRA · Each share of Class A Common Stock is sold with Series A and Series B warrants exercisable at $1.32 · Use of proceeds general corporate purposes · Underwriters Rodman & Renshaw LLC
2024-08-15 · 0001493152-24-032689
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
Begins the tracked draft filing sequence after 424B4.
2024-07-29 · 0001493152-24-029315
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $4.13 · 1,615,000 shares · Gross proceeds $6,665,625
Class A Common Stock · Exchange NASDAQ · Ticker SYRA · Over-allotment 242,250 · Each Unit consists of one share of Class A Common Stock and one Warrant to purchase one share of Class A Common Stock at $6.50 per share · Warrants to purchase one share of Class A Common Stock at $6.50 per share, exercisable for 5 years · Use of proceeds Use proceeds for marketing and sales, application development, research and development, and working capital · Flags dual_class, units, warrants · Underwriters Kingswood Capital Partners, LLC
2023-10-03 · 0001493152-23-035123
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 8-A12B and marks the registration effective.
2023-09-28 · 9999999995-23-002804
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows CERT and registers the class of securities for exchange listing.
2023-09-28 · 0001493152-23-034629
CERT inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows S-1/A in the pre-IPO sequence.
2023-09-28 · 0001354457-23-000710
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
Price $4.13 · 1,500,000 shares · Gross proceeds $6,187,500
Class A Common Stock · Exchange Nasdaq Capital Market · Ticker SYRA · Over-allotment 225,000 · Each Unit consists of one share of Class A Common Stock and one Warrant to purchase one share of Class A Common Stock at $6.50 per share · Warrants to purchase one share of Class A Common Stock at $6.50 per share, exercisable for five years · Use of proceeds Net proceeds will be used for marketing, sales, application development, R&D, and working capital · Flags dual_class, units, warrants · Underwriters Kingswood Capital Partners, LLC
2023-09-13 · 0001493152-23-032488
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1/A and supplements the active offering with updated prospectus details.
2023-09-06 · 0001493152-23-031827
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Price $4.13 · 1,500,000 shares · Gross proceeds $6,187,500
Class A Common Stock · Exchange Nasdaq · Ticker SYRA · Over-allotment 225,000 · Each Unit consists of one share of Class A common stock and one warrant to purchase one share of Class A common stock · Each warrant exercisable at $6.50 per share for 5 years · Use of proceeds Marketing and sales, application development, research and development, and working capital · Flags units, warrants · Underwriters Kingswood Capital Partners, LLC
2023-09-05 · 0001493152-23-031698
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Price $4.13 · 2,000,000 shares · Gross proceeds $8,250,000
Class A · Exchange Nasdaq Capital Market · Ticker SYRA · Over-allotment 300,000 · Unit includes 1 Class A share and 1 warrant · Warrants to purchase 1 share at $6.50, exercisable for 5 years · Use of proceeds Net proceeds will be used for marketing, sales, application development, R&D, and working capital · Flags dual_class, units, warrants · Underwriters Kingswood Capital Partners, LLC
2023-07-17 · 0001493152-23-024686
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
Price $4.13 · 2,000,000 shares · Gross proceeds $8,250,000
Class A · Exchange Nasdaq Capital Market · Ticker SYRA · Over-allotment 300,000 · Each Unit consists of one share of Class A Common Stock and one Warrant · Warrants to purchase one share of Class A Common Stock at $6.50 per share exercisable for 5 years · Use of proceeds Marketing and sales, application development, research and development, and working capital · Flags dual_class, units, warrants · Underwriters Kingswood Capital Partners, LLC
2023-07-06 · 0001493152-23-023837
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1/A and supplements the active offering with updated prospectus details.
2023-06-13 · 0001493152-23-020993
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Price $4.13 · 2,000,000 shares · Gross proceeds $8,250,000
Class A · Exchange Nasdaq · Ticker SYRA · Over-allotment 300,000 · Each Unit consists of one share of Class A common stock and one warrant to purchase one share of Class A common stock · Warrants to purchase one share of Class A common stock at $6.50 per share exercisable for five years · Use of proceeds For marketing and sales, application development, research and development, and working capital · Flags dual_class, units, emerging_growth_company · Underwriters Kingswood a division of Kingswood Capital Partners, LLC
2023-06-13 · 0001493152-23-020991
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
Price $4.13 · 2,000,000 shares · Gross proceeds $8,250,000
Class A Common Stock · Exchange Nasdaq · Ticker SYRA · Over-allotment 300,000 · Each Unit consists of one share of Class A Common Stock and one Warrant · Each Warrant entitles the holder to purchase one share of Class A Common Stock at an exercise price of $6.50 per share, exercisable for five years · Use of proceeds marketing and sales, application development, research and development, and working capital · Flags dual_class, units, warrants · Underwriters Kingswood
2023-05-04 · 0001493152-23-015347
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2023-01-30 · 0001493152-23-002912
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
Syra Health Corp's DRS/A filing highlights financials for the year ended December 31, 2021, showing net revenues of $1.3M, a net loss of $109,499, and a stockholders' deficit of $113,366. The company underwent a recapitalization in May 2022, converting 100,000 common shares to 1,000,000 convertible Class B shares. Additional capital raises included $1M from Class A share sales in March 2022 and $1.3M from subsequent placements. Key risks include reliance on Indiana FSSA for 98% of revenue, liquidity constraints, and a line of credit with variable interest rates. The company also disclosed significant related-party transactions and lease obligations under ASC 842.
2022-12-14 · 0001493152-22-035412
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
Syra Health Corp's DRS filing details financials from its inception in November 2020 through December 2021, highlighting its first full year of operations. The company generated $1.3M in net revenue in 2021 from clinical staffing and medical communication services, but reported a net loss of $109,499. Liquidity concerns are emphasized, with reliance on related-party advances and a $1.5M line of credit. The filing also notes stock sales in 2022 and risks related to operational scalability, contract penalties, and financing availability.
2022-11-02 · 0001493152-22-030203
Comparable Deals

20 comparable deals

TechnologyMicro (<$50M)Last 18 months
Only 0 strict matches; expanded to 20 using nearest neighbors.
Showing top 8 by similarity.
+3.3%
Median day-1
70%
Above issue
+2.2%
Median week-1
-20.0%
Downside (p10)
QumulusAI, Inc. QMLS
2026-07-16 - Day 1: -58.8% Wk 1: -77.6%
same SIC grouprecent IPO
Csquare, Inc. CSQR
2026-07-16 $1.1B Day 1: -1.6% Wk 1: +2.7%
same SIC grouprecent IPO
TechCreate Group Ltd. TCGL
2025-10-15 $10M Day 1: +23.2% Wk 1: +11.3%
same SIC grouprecent IPO
Neutron Holdings, Inc. LIME
2026-07-01 $174M Day 1: +4.0% Wk 1: +0.2%
same SIC grouprecent IPO
Bending Spoons S.p.A. BSP
2026-07-01 $954M Day 1: +39.7% Wk 1: +18.0%
same SIC grouprecent IPO
SPACE EXPLORATION TECHNOLOGIES CORP SPCX
2026-06-12 $75.0B Day 1: +19.2% Wk 1: +29.3%
same SIC grouprecent IPO
Liftoff Mobile, Inc. LFTO
2026-06-04 $437M Day 1: +21.2% Wk 1: +7.5%
same SIC grouprecent IPO
Quantinuum Inc. QNT
2026-06-04 $1.7B Day 1: +0.6% Wk 1: -7.9%
same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.